Academic Journal
Q1hLife
About hLife
hLife is a scholarly journal published by Elsevier B.V.. SCImago 2025 lists it in Q1, with an SJR of 2.077 and H-index of 14.
Coverage: 2023-2026. Research categories: Immunology and Allergy (Q1); Immunology and Microbiology (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Microbiology (medical) (Q1).
Open-access policies and author information
Reported in the official DOAJ public CSV snapshot (2026-09-01), downloaded 2026-10-03. Record updated 2026-04-27. This snapshot does not establish today’s listing status or fee quotation.
Publisher policy links recorded by DOAJ
- Aims and scope ↗
- Editorial board ↗
- Instructions for authors ↗
- Peer-review policy ↗
- Publication fees ↗
- Fee waivers ↗
- Licence terms ↗
- Copyright policy ↗
- Preservation policy ↗
Source: DOAJ journal record. Journal metadata is distributed by DOAJ under CC0. Confirm current fees, tax, eligibility and waiver terms with the publisher.
Source-backed journal facts
Topics in published research
SARS-CoV-2 and COVID-19 Research; Gut microbiota and health; COVID-19 Clinical Research Studies; Antibiotic Resistance in Bacteria; interferon and immune responses; vaccines and immunoinformatics approaches.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Targeted bacteriophage therapy alleviates enteroaggregative Escherichia coli-associated renal injury in diabetic kidney disease
Tao Wang, Jingzu Sun, Feiyue Cheng, Guan Wang et al.
2026-09 · DOI: 10.1016/j.hlife.2026.09.001Establishing a regulatory framework for phage therapy in China
Jixin Yang, Haiyan Chen, Xuesong He, Nannan Wu et al.
2026-09 · DOI: 10.1016/j.hlife.2026.05.001New insights into the skin immune landscape at single-cell resolution during cutaneous infection by an obligate intracellular bacterium
Tian-Feng An, Juan Wang, Li-Feng Du, Dong-Sheng Chen et al.
2026-09 · DOI: 10.1016/j.hlife.2026.09.002Conserved nucleocapsid epitopes induce cross-reactive CD4+ T-cell responses with selective protection against human coronaviruses in mice
Xiaomin Lai, Zhao Chen, Suoqun Zhao, Airu Zhu et al.
2026-09 · DOI: 10.1016/j.hlife.2026.07.004Branched-chain amino acid depletion and adolescent myopia progression through mTORC1-dependent scleral remodeling
Weina Liu, Jia Hu, Qinye Liu, Yingyun Shi et al.
2026-09 · DOI: 10.1016/j.hlife.2026.08.005Engineering organoids toward implantable living therapeutics
Zhicheng Shi, Qianrong Yang, Xiaoyan You, Hui Wang et al.
2026-09 · DOI: 10.1016/j.hlife.2026.06.002Efficacy and safety of XKH004, a novel dual interleukin-17A/F inhibitory monoclonal antibody, in active ankylosing spondylitis: A 52-week phase 3 randomized study
Ling Zhou, Ran Yan, Songying Ye, Juan Zhao et al.
2026-09 · DOI: 10.1016/j.hlife.2026.07.005A phage-based luminescent reporter platform for rapid typing of multiple capsular types of Klebsiella pneumoniae
Yiyao Song, Shisong Jing, Yi Li, Yinglu Guo et al.
2026-09 · DOI: 10.1016/j.hlife.2026.06.001Intranasal gold nanoparticle-antigen induces mucosal and systemic immunity against β-coronaviruses
Muzhuo Wang, Weijie Wang, Wei Xu, Zhikai Chen et al.
2026-09 · DOI: 10.1016/j.hlife.2026.07.002Recollections of an open U.S.–China anti-hantaviral clinical trial in the 1980s
Zhi-Ming Zheng
2026-09 · DOI: 10.1016/j.hlife.2026.05.006Unraveling Streptococcus suis: Epidemiology, pathogenesis, and interventions of an emerging zoonosis
Miao Zhang, Yuanjie Zhao, Jinxiu Wang, Mengmeng Liu et al.
2026-08 · DOI: 10.1016/j.hlife.2026.08.004Peptide-based henipavirus entry inhibitors as pandemic countermeasures
Qian Wang, Yuanzhou Wang, Lu Lu, Shibo Jiang et al.
2026-08 · DOI: 10.1016/j.hlife.2026.04.002Prospects for using mRNA vaccines against fungal infections
Yeqi Li, Xiaorong Lin
2026-08 · DOI: 10.1016/j.hlife.2026.02.002Genetic tool for specific tracking of mature neutrophils
Jiayu Cao, Hui Ping Yaw, Shilin Yi, Yanxi Zhou et al.
2026-08 · DOI: 10.1016/j.hlife.2026.05.007Golgi-derived COPI vesicles fuel the biogenesis of coronavirus replication organelles
Zhaohuan Wang, Xinyue Su, Kaoyi Gong, Zixiao Yang et al.
2026-08 · DOI: 10.1016/j.hlife.2026.06.004New design for universal respiratory vaccines: A new paradigm on integrated immunity
Zhen Liu, Shuo Wang
2026-08 · DOI: 10.1016/j.hlife.2026.05.005Driving the future of human immunology: A conversation with Professor Miriam Merad
Lai Guan Ng, Miriam Merad
2026-08 · DOI: 10.1016/j.hlife.2026.08.001Ex-Tregs: From controversial artifact to therapeutic target
Liping Li, Minghui Li, Xuyu Zhou
2026-08 · DOI: 10.1016/j.hlife.2026.05.002LARGE: A large language model-based tool that unveils high-resolution temporal dynamics of the antibiotic resistome during human aging
Hang He, Chenrui Duan, Kui Deng, Chang Su et al.
2026-08 · DOI: 10.1016/j.hlife.2026.08.002Rationally designed common-light-chain anti-EGFR/c-MET bispecific antibody ALK101 demonstrates potent, broad-spectrum antitumor activity
Linrui Jiang, Xiaonan Han, Hongwang He, Mengfan Peng et al.
2026-08 · DOI: 10.1016/j.hlife.2026.08.003Reviews
Community Reviews
Version History
September 25, 2026 at 7:10 am
September 25, 2026